Skip to content
akaturk Academic measurement
2025 SJR Q3 JCR Q3 · 2 112 matched articles SCIE

Journal detail

Anti-Cancer Drugs

Publisher
Lippincott Williams and Wilkins
Country
United States · Northern America
Type
journal
ISSN
  • 09594973
  • 14735741
Scopus 0,506 SJR
Scopus Q3 SJR Q
WoS Q3 JCR Q
WoS 2 JIF
Scopus 106 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 0,506
  • Quartile Q3
  • H-Index 106
  • Cites/doc 1,96
  • Docs (3y) 517
  • Cites (3y) 1.033

Clarivate

Web of Science · JCR · 2025

  • JCR Q Q3
  • JIF 2
  • 5Y JIF 1,9
  • JCI 0,56

WoS indexes

  • SCIE

Subject classification

Categories (SJR)

  • Cancer Research Q4
  • Oncology Q3
  • Pharmacology Q3
  • Pharmacology (medical) Q3

Areas

  • Biochemistry, Genetics and Molecular Biology
  • Medicine
  • Pharmacology, Toxicology and Pharmaceutics

WoS categories

  • Oncology | Pharmacology & Pharmacy

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2025 Q3 Q3 0,506 2 1,9 0,56 Q3 106
2024 Q3 Q3 0,532 2,2 1,9 0,6 Q3 105
2023 Q3 Q3 0,476 1,8 1,9 0,63 Q3 105
2022 Q3 Q3 0,471 2,3 2,3 0,58 Q3 105
2021 Q3 Q4 0,463 2,4 2,4 0,57 Q3 105
2020 Q2 Q4 0,651 2,2 2,3 0,61 Q3 105
2019 Q2 Q3 0,636 2,3 2 0,65 Q3 105
2018 — Q3 — 1,8 1,9 0,64 Q3 —
2017 Q2 Q3 0,716 1,9 2 0,67 Q3 105
2016 Q2 Q3 0,78 2,3 2 — — 105
2015 Q2 Q3 0,783 2,3 2 — — 105
2014 Q2 Q3 0,744 1,8 2,1 — — 105
2013 Q2 Q3 0,836 1,9 2,2 — — 105
2012 Q1 Q2 0,936 2,2 2,3 — — 105
2011 Q1 Q2 0,991 2,4 2,2 — — 105
2010 Q2 Q2 0,913 2,4 2,2 — — 105
2009 — Q3 — 2,2 2,2 — — —
2008 — Q2 — 2,4 2,3 — — —
2007 — Q2 — 2,4 2,1 — — —
2006 — Q2 — 2,2 — — — —
2005 — Q2 — 1,9 — — — —
2004 — Q2 — 2,1 — — — —
2003 — Q2 — 1,9 — — — —
2002 — Q2 — 2 — — — —
2001 — Q2 — 1,5 — — — —
2000 — Q2 — 1,6 — — — —
1999 — Q2 — 1,6 — — — —
1998 — Q2 — 1,3 — — — —
1997 — Q3 — 1 — — — —

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year Category Edition JCR Q (1997+) JCI Q (1997+) Rank
2025 ONCOLOGY SCIE Q4 Q3 250/333
2025 PHARMACOLOGY & PHARMACY SCIE Q3 Q3 249/356
2024 ONCOLOGY SCIE Q3 Q3 217/328
2024 PHARMACOLOGY & PHARMACY SCIE Q3 Q3 209/352
2023 ONCOLOGY SCIE Q3 Q3 241/322
2023 PHARMACOLOGY & PHARMACY SCIE Q3 Q3 240/354
2022 ONCOLOGY SCIE Q4 Q3 196/241
2022 PHARMACOLOGY & PHARMACY SCIE Q3 Q3 200/278
2021 ONCOLOGY SCIE Q4 Q3 208/245
2021 PHARMACOLOGY & PHARMACY SCIE Q4 Q3 211/279
2020 ONCOLOGY SCIE Q4 Q3 218/242
2020 PHARMACOLOGY & PHARMACY SCIE Q4 Q3 209/276
2019 ONCOLOGY SCIE Q4 Q3 184/244
2019 PHARMACOLOGY & PHARMACY SCIE Q3 Q3 177/271
2018 ONCOLOGY SCIE Q4 Q3 194/230
2018 PHARMACOLOGY & PHARMACY SCIE Q3 Q3 195/267
2017 ONCOLOGY SCIE Q4 Q3 182/223
2017 PHARMACOLOGY & PHARMACY SCIE Q3 Q3 187/261
2016 ONCOLOGY SCIE Q3 — 144/217
2016 PHARMACOLOGY & PHARMACY SCIE Q3 — 135/257
2015 ONCOLOGY SCIE Q3 — 138/213
2015 PHARMACOLOGY & PHARMACY SCIE Q3 — 131/255
2014 ONCOLOGY SCIE Q4 — 165/211
2014 PHARMACOLOGY & PHARMACY SCIE Q3 — 163/255
2013 ONCOLOGY SCIE Q3 — 143/203
2013 PHARMACOLOGY & PHARMACY SCIE Q3 — 155/256
2012 ONCOLOGY SCIE Q3 — 115/197
2012 PHARMACOLOGY & PHARMACY SCIE Q2 — 127/261
2011 ONCOLOGY SCIE Q3 — 109/196
2011 PHARMACOLOGY & PHARMACY SCIE Q2 — 116/261
2010 ONCOLOGY SCIE Q3 — 100/185
2010 PHARMACOLOGY & PHARMACY SCIE Q2 — 123/252
2009 ONCOLOGY SCIE Q3 — 90/166
2009 PHARMACOLOGY & PHARMACY SCIE Q3 — 123/237
2008 ONCOLOGY SCIE Q3 — 82/143
2008 PHARMACOLOGY & PHARMACY SCIE Q2 — 105/219
2007 ONCOLOGY SCIE Q3 — 76/132
2007 PHARMACOLOGY & PHARMACY SCIE Q2 — 86/205
2006 ONCOLOGY SCIE Q3 — 72/127
2006 PHARMACOLOGY & PHARMACY SCIE Q2 — 86/199
2005 ONCOLOGY SCIE Q3 — 74/123
2005 PHARMACOLOGY & PHARMACY SCIE Q2 — 94/193
2004 ONCOLOGY SCIE Q3 — 69/123
2004 PHARMACOLOGY & PHARMACY SCIE Q2 — 76/187
2003 ONCOLOGY SCIE Q3 — 71/120
2003 PHARMACOLOGY & PHARMACY SCIE Q2 — 78/185
2002 ONCOLOGY SCIE Q2 — 57/114
2002 PHARMACOLOGY & PHARMACY SCIE Q2 — 61/188
2001 ONCOLOGY SCIE Q3 — 64/107
2001 PHARMACOLOGY & PHARMACY SCIE Q2 — 82/186
2000 ONCOLOGY SCIE Q3 — 55/103
2000 PHARMACOLOGY & PHARMACY SCIE Q2 — 74/181
1999 ONCOLOGY SCIE Q2 — 50/105
1999 PHARMACOLOGY & PHARMACY SCIE Q2 — 64/175
1998 ONCOLOGY SCIE Q3 — 56/104
1998 PHARMACOLOGY & PHARMACY SCIE Q2 — 75/178
1997 ONCOLOGY SCIE Q3 — 62/102
1997 PHARMACOLOGY & PHARMACY SCIE Q3 — 94/157